Literature DB >> 17447090

Differentiation of Candida albicans from non-albicans yeast directly from blood cultures by Gram stain morphology.

A Harrington1, K McCourtney, D Nowowiejski, A Limaye.   

Abstract

Clusters of pseudohyphae are commonly seen on Gram stain of blood cultures from patients with Candida albicans fungemia. Whether this morphologic feature is useful for differentiating C. albicans from other yeasts has not previously been systematically evaluated. Yeast morphology on Gram stain of blood cultures from consecutive patients with fungemia detected by the Bactec automated blood culture system was prospectively assessed and correlated with the final culture-based yeast identification. The distribution of yeast in 60 consecutive patients with fungemia included Candida spp. (C. albicans 43%, Candida glabrata 28%, Candida parapsilosis 8%, Candida krusei 7%, Candida tropicalis 5%, Candida dubliniensis 2%, and Candida lusitaniae 2%), Rhodotorula mucilaginosa 2%, and Cryptococcus neoformans 3%. Upon analysis of the first positive blood culture bottle per patient, the presence of clustered pseudohyphae on Gram stain had a sensitivity, specificity, positive predictive value, and negative predictive value of 85, 97, 96, and 89%, respectively, for C. albicans. The sensitivity and specificity of aerobic vs Myco/F blood culture bottles were 96 and 95% vs 25 and 100%, p < 0.001, respectively. Inter-rater agreement for ten separate observations among five reviewers was 100%. The presence of pseudohyphae clusters by Gram stain of blood cultures is useful in distinguishing C. albicans from non-albicans yeast. Additional studies are necessary to determine the clinical impact of these findings and their validity with other blood culture systems.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17447090     DOI: 10.1007/s10096-007-0291-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  5 in total

1.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

2.  Activities of fluconazole and voriconazole against 1,586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and Etest methods: report from the ARTEMIS Global Antifungal Susceptibility Program, 2001.

Authors:  M A Pfaller; D J Diekema; S A Messer; L Boyken; R J Hollis
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Trends in antifungal susceptibility of Candida spp. isolated from pediatric and adult patients with bloodstream infections: SENTRY Antimicrobial Surveillance Program, 1997 to 2000.

Authors:  M A Pfaller; D J Diekema; R N Jones; S A Messer; R J Hollis
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

4.  Peptide nucleic acid fluorescence in situ hybridization-based identification of Candida albicans and its impact on mortality and antifungal therapy costs.

Authors:  G N Forrest; K Mankes; M A Jabra-Rizk; E Weekes; J K Johnson; D P Lincalis; R A Venezia
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  Rapid identification of commonly encountered Candida species directly from blood culture bottles.

Authors:  Rangaraj Selvarangan; Uyen Bui; Ajit P Limaye; Brad T Cookson
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

  5 in total
  4 in total

1.  Endocarditis caused by Rhodotorula infection.

Authors:  Matthew S Simon; Selin Somersan; Harjot K Singh; Barry Hartman; Brian L Wickes; Stephen G Jenkins; Thomas J Walsh; Audrey N Schuetz
Journal:  J Clin Microbiol       Date:  2013-11-06       Impact factor: 5.948

2.  Utility of the germ tube test for direct identification of Candida albicans from positive blood culture bottles.

Authors:  Donald C Sheppard; Marie-Claude Locas; Christiane Restieri; Michel Laverdiere
Journal:  J Clin Microbiol       Date:  2008-08-06       Impact factor: 5.948

3.  Central line-associated Rhodotorula mucilaginosa fungemia in an immunocompetent host: Case report and review of the literature.

Authors:  Wael Goravey; Gawahir A Ali; Fatma Abid; Emad B Ibrahim; Muna A Al Maslamani; Hamad Abdel Hadi
Journal:  Clin Case Rep       Date:  2021-02-20

4.  Magnusiomyces capitatus fungemia: The value of direct microscopy in early diagnosis.

Authors:  Khaled Alobaid; Abrar Ali Abdullah; Suhail Ahmad; Leena Joseph; Ziauddin Khan
Journal:  Med Mycol Case Rep       Date:  2019-07-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.